cinnamomum zeylanicum bark powder hamilelikte güvenli mi?
No harmonised reproductive classification in ECHA Annex VI and no CIR/SCCS or strong peer‑reviewed evidence that Cinnamomum zeylanicum bark powder or its typical constituents are teratogenic or have reproductive toxicity. Main documented risks are topical irritation/sensitisation from cinnamaldehyde/eugenol rather than reproductive effects (sources: ECHA Annex VI (no harmonised reproductive classification), CIR review(s) of cinnamon ingredients, PubMed literature on cinnamon constituents).
Pregnancy-safe products containing cinnamomum zeylanicum bark powder
Related ingredients
Frequently asked questions
- cinnamomum zeylanicum bark powder hamilelikte güvenli mi?
- No harmonised reproductive classification in ECHA Annex VI and no CIR/SCCS or strong peer‑reviewed evidence that Cinnamomum zeylanicum bark powder or its typical constituents are teratogenic or have reproductive toxicity. Main documented risks are topical irritation/sensitisation from cinnamaldehyde/eugenol rather than reproductive effects (sources: ECHA Annex VI (no harmonised reproductive classification), CIR review(s) of cinnamon ingredients, PubMed literature on cinnamon constituents).
- cinnamomum zeylanicum bark powder emzirirken güvenli mi?
- No data indicating systemic reproductive/toxic effects that would contraindicate use during lactation. Primary safety concerns are topical skin irritation/sensitisation; there is no authoritative classification (H360/H361) or clinical evidence indicating harm to nursing infants from topical use of the bark powder (sources: ECHA Annex VI, CIR, PubMed).
- cinnamomum zeylanicum bark powder bebek cildi için güvenli mi?
- No evidence of reproductive or developmental toxicity specific to infants. However, constituents (cinnamaldehyde, eugenol) are known skin irritants and contact sensitizers; infant skin has higher permeability and a higher surface-area-to-weight ratio so exposure potential is increased compared with adults — therefore exposure score raised by +1. Avoid use on infant (0–3 yr) skin due to irritation/sensitisation risk rather than reproductive toxicity (sources: PubMed on cinnamon sensitisation, CIR, CosIng ingredient listings).
- VeriMom cinnamomum zeylanicum bark powder nasıl puanlıyor?
- VeriMom cinnamomum zeylanicum bark powder'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte cinnamomum zeylanicum bark powder yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.



